Accuray's weak quarter signals ongoing challenges despite new CEO plans. Discover key insights and risks before investing in ...

Accuray Incorporated ARAY reported third-quarter fiscal 2025 loss per share of a cent compared with the year-ago period’s loss of 6 cents. The bottom line surpassed the Zacks Consensus Estimate by 80% ...

The average one-year price target for Accuray (NasdaqGS:ARAY) has been revised to $4.84 / share. This is a decrease of 13.64% ...

Accuray Incorporated (NASDAQ: ARAY) and Halifax Health announced a breakthrough in cancer treatment at the Charles L. and Miki N. Grant Cancer Center for Hope in Port Orange, FL. Zacks Russell 2000 ...

(ARAY) on Wednesday reported a loss of $21.7 million in its fiscal first quarter. The Madison, Wisconsin-based company said it had a loss of 18 cents per share. The radiation oncology company posted ...

Last year’s fourth quarter was a rough one for investors and many hedge funds, which were naturally unable to overcome the big dip in the broad market, as the S&P 500 fell by about 4.8% during 2018 ...

$ARAY insiders have traded $ARAY stock on the open market 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales. Here’s a ...

Momentum investing is essentially the opposite of the tried-and-tested Wall Street adage -- "buy low and sell high." Investors following this investing style typically avoid betting on cheap stocks ...

Accuray Incorporated ARAY recently revealed findings from an international multicenter analysis, showing that the CyberKnife System delivers effective and time-efficient treatment for brainstem ...